الإنهاء الطبي للحمل في الثلث الثاني بواسطة البروستاغلاندين E1
Abstract
أجريت الدراسة في قسم التوليد وأمراض النساء – مشفى الأسد الجامعي – اللاذقية وامتدت من تاريخ 1/1/2003 وحتى 30/6/2004 وضمت 48 مريضة وكانت نتائج الدراسة على النحو التالي:
- أعلى نسبة موت محصول حمل وتشوه أجنة تقع ضمن مجموعة 25-29 سنة (37.5%).
- أعلى نسبة موت محصول حمل وتشوه أجنة توجد عند الولودات (64.58%).
حدث خروج محصول الحمل خلال 16ساعة من بدء تطبيق البروستاغلاندين E1 عند37 مريضة ( 77.1%).
- تم استخدام الأوكسيتوسين لدى 11 مريضة (22.9%) وذلك بعد 16 ساعة من بدء تطبيق البروستاغلاندين E1وحدثت الاستجابة لدى معظم تلك المريضات خلال فترة أقصاها 6 ساعات .
- كانت هناك حاجة لإجراء تجريف رحم بعد خروج محصول الحمل عند 33 مريضة (68.75%).
- الآثار الجانبية المشاهدة هي:
- الغثيان (8.3%)
- فرط الاستثارة الرحمية (6.3%)
- الترفع الحروري(2%)
The study was carried out in the obstetrics and gynecology department at ALASSAD university hospital in Lattakia between 1/1/2003 and 30/6/2004
The study included 48 patients and the results were:
- The highest rate of fetal death and fetal malformations was in the patients aged between 25-29 years (37.5%).
- The highest incidence of fetal death and fetal malformations was in the multipara patients (64.58%).
- The expulsion of the contents was happened during 16 hours after administration of prostaglandin E1in 37 patients (77,1%)
- Oxcytocin was used in 11 patients (22,9%) after administration of prostaglandin E1and the expulsion happened during 6 hours at the majority of these patients.
- There was a need for uterine curettage after the expulsion of the contents in 33 patients (68,75%)
- Side effects were:
-nausea (8,3%),
-uterine hyperstimulation (6,3%)
-fever (2%)
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.